fenofibric acid has been researched along with farglitazar in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajamie, RT; Briere, DA; Brozinick, JT; Devanarayan, V; Hawkins, ED; Henry, JR; Li, Y; Misener, EA; Montrose-Rafizadeh, C; Warshawsky, AM; Wilken, B; Yumibe, NP; Zink, RW | 1 |
1 other study(ies) available for fenofibric acid and farglitazar
| Article | Year |
|---|---|
Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents.
Topics: Animals; Blood Glucose; Humans; Hypoglycemic Agents; Mice; Models, Molecular; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Rosiglitazone; Tetrahydroisoquinolines; Thiazolidinediones | 2006 |